| Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas. | |
| | |
MedLine Citation:
|
PMID: 19756593 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: The goal of this study was to analyze protein expression of antigen processing machinery (APM) components in bladder carcinoma (BC), and to assess the clinical significance of defects in their expression. EXPERIMENTAL DESIGN: Tissue from 167 cystectomies for primary BC was used to create a tissue microarray. 128 tumors were urothelial carcinoma (UC). Immunohistochemistry was performed using 14 monoclonal antibodies to APM components (beta2-microglobulin, calnexin, calreticulin, delta, Z, MB1, LMP2, LMP7, LMP10, HLA class I heavy chain, tapasin, TAP1, TAP2 and ERp57) and MHC class I-related antigen (MICA). Sections of normal urothelium from six subjects were used as controls. RESULTS: All APM components except MB1, LMP2 and TAP2 had significantly lower staining in UC than in normal urothelium. No significant differences were found in APM component scores between different grades of UC. Squamous cell carcinoma had the highest scores, with UC intermediate and other types of BC lowest. High-stage UC demonstrated significantly lower staining for calnexin, LMP2, LMP7 and LMP10 than low-stage UC. With mean 3.6 years follow up, significantly worse survival was associated with a higher delta score in UC (P = 0.038) and a lower calreticulin score in all tumor types (P = 0.028). CONCLUSIONS: Most APM components were downregulated in UC. High-stage UC had lower scores for immunoproteasome components compared to low-stage UC. Delta and calreticulin protein expression was associated with survival in UC and in all types of BC, respectively. These findings suggest that APM defects play a role in the clinical course of BC and should be considered in developing immunotherapeutic approaches for its control. |
| | |
Authors:
|
Helen P Cathro; Mark E Smolkin; Dan Theodorescu; Vickie Y Jo; Soldano Ferrone; Henry F Frierson |
Related Documents
:
|
10506443 - Comparison of glycoprotein expression between ovarian and colon adenocarcinomas. 2829493 - Monoclonal antibody ery-1 identifies an antigen in erythroid cells, hepatocellular and ... 22339323 - Oral delivery of microparticles containing plasmid dna encoding hepatitis-b surface ant... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. Date: 2009-09-16 |
Journal Detail:
|
Title: Cancer immunology, immunotherapy : CII Volume: 59 ISSN: 1432-0851 ISO Abbreviation: Cancer Immunol. Immunother. Publication Date: 2010 Mar |
Date Detail:
|
Created Date: 2010-01-21 Completed Date: 2010-03-09 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8605732 Medline TA: Cancer Immunol Immunother Country: Germany |
Other Details:
|
Languages: eng Pagination: 465-72 Citation Subset: IM |
Affiliation:
|
Department of Pathology, University of Virginia Health System, Charlottesville, 22908, USA. hpc4f@virginia.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antibodies, Monoclonal Antigen Presentation* / immunology Carcinoma, Squamous Cell / immunology, pathology Carcinoma, Transitional Cell / immunology Female Histocompatibility Antigens Class I / immunology* Humans Male Tissue Array Analysis* Urinary Bladder Neoplasms / immunology*, mortality, pathology Urothelium / immunology |
| Grant Support | |
ID/Acronym/Agency:
|
P01CA109688/CA/NCI NIH HHS; R01CA110249/CA/NCI NIH HHS; R01CA113861/CA/NCI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Histocompatibility Antigens Class I |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prost...
Next Document: Natural killer cell is a major producer of interferon gamma that is critical for the IL-12-induced a...